Tazarotene

Tazarotene is a member of the acetylenic class of retinoids and is regarded as a third-generation topical retinoid, meaning a synthetic relative of vitamin A designed for application to the skin ^[3]. It is a prodrug: after entering the skin it is rapidly converted by esterase enzymes into its active metabolite, tazarotenic acid ^[1]. It reached the market in the late 1990s and is sold under brand names such as Tazorac and Avage, with generic versions now available ^[3].

The drug is approved for plaque psoriasis, in which it helps normalize the overgrowth and faulty maturation of skin cells, and for acne, where it promotes the shedding of cells that would otherwise plug the pores ^[2][3]. It is also used cosmetically to improve photoaged skin, reducing fine wrinkles and the mottled pigmentation caused by sun exposure ^[3]. In treating psoriasis it is often paired with a topical corticosteroid, a combination that improves results and reduces irritation ^[3].

Tazarotenic acid works by binding retinoic acid receptors in skin cells, chiefly the RAR-beta and RAR-gamma subtypes, and thereby altering the activity of genes that control how keratinocytes grow and differentiate ^[2]. Because it is applied topically and only a small fraction is absorbed into the bloodstream, systemic exposure is low ^[1]. Tazarotene is a prescription medicine and comes in several formulations, including gels, creams, a lotion, and a foam; like other retinoids it is contraindicated in pregnancy because of the risk of harm to a developing fetus ^[3]. The most common drawback is local skin irritation, which is usually mild to moderate ^[3].

Tazarotene is prescription only. Most effects are local: burning, stinging, redness, dryness, peeling, and itching, especially in the first few weeks, and it raises sun sensitivity. It is teratogenic and carries a pregnancy category X rating, so it is contraindicated in pregnancy, and women who can become pregnant need effective contraception while using it. Do not apply it to sunburned or eczema-prone skin, and pair it with daytime sunscreen and a moisturizer; starting every other day helps when irritation runs high.

Tazarotene is contraindicated in pregnancy; like other retinoids, it is a documented teratogen with significant risk of congenital abnormalities including cleft palate, heart defects, central nervous system malformations, and thymic aplasia. Women of childbearing potential using tazarotene must use effective contraception and understand that the drug can cause severe fetal harm even at topical doses.

Tazarotene exhibits photosensitizing properties when exposed to UVA and UVB light; the compound forms long-lived triplet excited states under UVA exposure that generate reactive singlet oxygen and may form photoproducts with skin proteins like tryptophan, leading to phototoxic reactions in sun-exposed skin ^[19]. Users should expect enhanced photosensitivity and avoid or minimize sun exposure during treatment, or use rigorous photoprotection including broad-spectrum sunscreen and protective clothing. While tazarotene is sometimes used alongside narrow-band UVB phototherapy for psoriasis, this combination requires close clinical monitoring due to increased photosensitivity risk.

Checking a whole stack? Run it through interactions + stacks.

Tazarotene was developed by Allergan and introduced in the late 1990s, receiving US FDA approval in 1997 for plaque psoriasis and acne vulgaris under the brand name Tazorac (marketed as Zorac in some regions). It was one of the first of the so-called third-generation topical retinoids, a class of acetylenic compounds engineered for greater receptor selectivity than earlier vitamin-A derivatives.

Chemically it was designed as a prodrug that the skin rapidly converts to its active form, tazarotenic acid, which binds selectively to the RAR-beta and RAR-gamma retinoic acid receptors. Over the following two decades its indications broadened to include photodamage and fine facial wrinkling, and newer vehicles were developed, including foam (Fabior), a lower-strength lotion (Arazlo), and a fixed combination with the corticosteroid halobetasol to improve tolerability in psoriasis. It remains a prescription retinoid and, like others in its class, is contraindicated in pregnancy.

Tazarotene has a solid reputation among dermatologists as a potent and versatile topical retinoid, notable for being one of the few approved for both acne and psoriasis. In psoriasis it produces meaningful reductions in plaque elevation and scaling and, distinctively, tends to sustain its benefit after treatment stops, a property that has made it attractive for maintenance regimens and for pairing with topical corticosteroids to offset steroid-induced skin thinning.

In acne it promotes healthy turnover of the cells lining the pores, helping to keep them clear. Its relatively high potency is a double-edged quality: it is effective, but it is also among the more irritating retinoids, and the dryness, redness, and peeling of the early retinization period lead some users to combine it with moisturizers or a corticosteroid. Only a small fraction is absorbed into the bloodstream, which limits systemic effects.